Related references
Note: Only part of the references are listed.Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG)
Winfred C. Wang et al.
LANCET (2011)
The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS)
Ersi Voskaridou et al.
BLOOD (2010)
Hydroxyurea therapy requires HbF induction for clinical benefit in a sickle cell mouse model
Jeffrey D. Lebensburger et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directions
Gregory J. Kato et al.
AMERICAN JOURNAL OF HEMATOLOGY (2009)
Prediction of adverse outcomes in children with sickle cell anemia: a study of the Dallas Newborn Cohort
Charles T. Quinn et al.
BLOOD (2008)
Chronic Hyper-Hemolysis in Sickle Cell Anemia: Association of Vascular Complications and Mortality with Less Frequent Vasoocclusive Pain
James G. V. Taylor et al.
PLOS ONE (2008)
MRI abnormalities of the brain in one-year-old children with sickle cell anemia
Winfred C. Wang et al.
PEDIATRIC BLOOD & CANCER (2008)
Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East London
Paul Telfer et al.
HAEMATOLOGICA (2007)
Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine
Natasha B. Halasa et al.
CLINICAL INFECTIOUS DISEASES (2007)
Deconstructing sickle cell disease: Reappraisal of the role of hemolysis in the development of clinical subphenotypes
Gregory J. Kato et al.
BLOOD REVIEWS (2007)
Outcome of sickle cell anemia - A 4-decade observational study of 1056 patients
DR Powars et al.
MEDICINE (2005)
Prediction of adverse outcomes in children with sickle cell disease
ST Miller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
